Free Trial

Haemonetics (HAE) SEC Filings & 10K Form

Haemonetics logo
$71.53 -0.61 (-0.85%)
Closing price 03:59 PM Eastern
Extended Trading
$71.44 -0.09 (-0.13%)
As of 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Haemonetics SEC Filings

DateFilerForm TypeView
06/09/2025
3:49 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:17 PM
Haemonetics (Filer)
Form DEF 14A
06/06/2025
3:18 PM
Haemonetics (Filer)
Form DEFA14A
06/04/2025
9:06 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
3:41 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:31 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
12:16 PM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
3:21 PM
Haemonetics (Filer)
Form SD
Specialized Disclosure Report  
05/21/2025
5:12 AM
Haemonetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/20/2025
4:21 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:24 PM
Chan Frank (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:28 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:31 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:10 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:14 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:17 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:15 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:17 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
9:47 AM
Haemonetics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
05/12/2025
9:44 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/08/2025
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
3:16 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:24 PM
Capital Research Global Investors (Filed by)
Haemonetics (Subject)
Form SCHEDULE 13G/A
02/06/2025
5:19 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
5:20 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/14/2025
5:21 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
5:08 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:07 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
10:26 AM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
9:41 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:11 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:17 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:20 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
5:05 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2024
3:23 PM
Haemonetics (Filer)
Form 8-K/A
07/29/2024
4:03 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:29 PM
COYLE MICHAEL J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Bryant Diane M (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
07/26/2024
3:32 PM
ABERNATHY ROBERT E (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:34 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:21 PM
Haemonetics (Issuer)
Zane Ellen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:47 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:10 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
3:27 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:25 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
3:42 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:HAE) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners